Freiburg, Germany

Christoph Schächtele

This inventor holds 1 USPTO granted patent. Top assignee: Willmar Schwabe Gmbh & Co.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christoph Schächtele. Retrieved from https://idiyas.com/inventor/christoph-schandaumlchtele

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christoph Schächtele: Innovator in Alzheimer's Treatment

Introduction

Christoph Schächtele is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of Alzheimer's disease. His innovative work has led to the development of a unique patent that addresses critical health challenges.

Latest Patents

One of Christoph Schächtele's most significant patents is for "Stable hyperforin salts, method for producing same and their use in the treatment of Alzheimer's disease." This patent highlights his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Christoph Schächtele is associated with Willmar Schwabe GmbH & Co., a company known for its dedication to herbal medicine and innovative pharmaceutical solutions. His role in the company has allowed him to focus on research and development, contributing to groundbreaking advancements in healthcare.

Collaborations

Throughout his career, Christoph has collaborated with esteemed colleagues such as Shyam Sunder Chatterjee and Clemens Erdelmeier. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Christoph Schächtele is a distinguished inventor whose work in the treatment of Alzheimer's disease has the potential to make a significant impact on healthcare. His dedication to innovation and collaboration continues to inspire advancements in medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…